ClinicalTrials.gov
public full text
Public Domain
Dose Ranging Study in Elective Total Hip Replacement Surgery
The primary objective is to: * demonstrate the efficacy of SR123781A in the prevention of venous thromboembolism (VTE) by the demonstration of a dose-response in patients undergoing total hip replacement surgery. The secondary objectives are to: * evaluate the safety of SR123781A in the prevention of VTE after elective total hip replacement surgery; and * to assess the SR123781A pharmacokinetic profile in patients undergoing elective total hip replacement surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Methylprednisolone After Total Hip Arthroplasty#1074143
- Thromboelastography (TEG) and Clopidogrel Withdrawal Time in Elderly Patients With Hip Fracture#851995
- A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery#869759
- Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery#1060559
- Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.#906169
Record · ID 850293
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive